| Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment J Cao, L Chow, S Dow Frontiers in Oncology 13, 1116016, 2023 | 12 | 2023 |
| Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity JW Cao, J Lake, R Impastato, L Chow, L Perez, L Chubb, J Kurihara, ... Cancer Immunology, Immunotherapy 73 (5), 77, 2024 | 3 | 2024 |
| Expanding the scope of WT1-and cyclin A1-specific TCR gene therapy for AML and other cancers R Perret, K Valliant-Saunders, JW Cao, PD Greenberg The Journal of Immunology 196 (1_Supplement), 143.5-143.5, 2016 | 2 | 2016 |
| Canine osteosarcoma as a solid tumor model for evaluation of dual valent B7H3-CXCR2 CAR T cell therapy JW Cao, J Lake, L Chow, D Ammons, L Perez, R Impastato, J Kurihara, ... The Journal of Immunology 210 (1_Supplement), 159.22-159.22, 2023 | 1 | 2023 |
| Establishing Canine Osteosarcoma as a Solid Tumor Model for the Evaluation of B7-H3 CAR T Cell Therapy J Cao Colorado State University, 2023 | | 2023 |
| Expanding the scope of TCR gene therapy for the treatment of AML and other cancers R Perret, K Valliant-Saunders, J Cao, P Greenberg EUROPEAN JOURNAL OF IMMUNOLOGY 46, 517-518, 2016 | | 2016 |
